This inventor holds 1 USPTO granted patent. Top assignee: Bayer Intellectual Property Gmbh. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Masaru Honjo: Innovator in Medicinal Chemistry
Introduction
Masaru Honjo is a distinguished inventor based in Omuta, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for therapeutic use. His work has been recognized for its potential impact on the treatment of various diseases.
Latest Patents
Honjo holds a patent for N-(2-aminophenyl)-4-[N-(pyridine-3-yl)-methoxycarbonyl-aminomethyl]-benzamide (MS-275) polymorph B. This patent describes the crystalline Polymorph B of the compound, along with the process for its production and its application as a medicament for treating selected diseases. This innovation showcases his expertise in creating effective pharmaceutical agents.
Career Highlights
Masaru Honjo is currently associated with Bayer Intellectual Property GmbH, where he continues to advance his research in medicinal chemistry. His work has contributed to the development of new therapeutic options, enhancing the quality of healthcare.
Collaborations
Throughout his career, Honjo has collaborated with notable colleagues, including Tomoyuki Ando and Matthias Schneider. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Masaru Honjo's contributions to medicinal chemistry and his innovative patent for MS-275 polymorph B highlight his role as a key figure in the field. His ongoing work at Bayer Intellectual Property GmbH continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile